GlassScriptPhysician profile
Kalyanam Shivkumar
NPI 1144240748
$41,091.71
in general payments reported to CMS, 2019-2025
8 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.74 · 2021: $2,500 · 2022: $15K · 2023: $5,104 · 2024: $5,922 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Consulting Fee: $5,878 · Travel and Lodging: $3,591 · Food and Beverage: $1,551 · Grant: $147 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,045.00 |
| Consulting Fee | $5,877.50 |
| Travel and Lodging | $3,590.62 |
| Food and Beverage | $1,550.64 |
| Grant | $147.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $27,043.23 | 2022-2025 | Rivacor 7 Dr-T, Sentus, Edora 8 Dr-T |
| Boston Scientific Corporation | $8,381.26 | 2021-2025 | Farapulse, General - Therapies |
| Pacira Pharmaceuticals Incorporated | $2,545.70 | 2022-2023 | Exparel |
| Medtronic, INC. | $2,170.00 | 2022-2023 | Selectsecure |
| Abbott Laboratories | $710.79 | 2023-2024 | Ensite Precision, Ensite, Aveir |
| Ablacon, INC. | $182.89 | 2023 | |
| Biosense Webster, INC. | $57.84 | 2019-2025 | Carto 3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,568,566.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalyanam Shivkumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.